Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 hour ago“Our top priority is executing on our strategy to accelerate the development and delivery of transformative medicines for patients, and we are confident that we can accomplish this mission while ...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 6 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
MoonLake Immunotherapeutics Reports Q1 2024 Financial Outcomes
Guru Focus· 2 days agoReported Net Loss: $13.98 million for Q1 2024, below the estimated net loss of $13.21 million.Earnings Per Share (EPS): Recorded a loss of $0.22 per share, bel
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 2 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 6 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 6 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
Amgen (NASDAQ:AMGN) Rating Increased to Outperform at William Blair
ETF DAILY NEWS· 4 days agoAmgen (NASDAQ:AMGN – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Friday, MarketBeat ...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Average Recommendation of “Moderate Buy” from...
ETF DAILY NEWS· 3 days agoShares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twelve research firms that are presently covering the firm ...
Investors Purchase Large Volume of Bristol-Myers Squibb Put Options (NYSE:BMY)
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) saw some unusual options trading on Wednesday. Investors bought 69,538 put options on the company. This represents an increase of 76% compared ...
Bristol-Myers Squibb (NYSE:BMY) Given Average Rating of “Hold” by Analysts
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) has earned an average rating of “Hold” from the nineteen ratings firms that are currently covering the firm, MarketBeat.com reports. One research ...